Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2010

01.02.2010 | 2009 SSAT Plenary Presentation

Outcome Based on Management for Duodenal Adenomas: Sporadic Versus Familial Disease

verfasst von: Michael David Johnson, Richard Mackey, Nancy Brown, James Church, Carol Burke, R. Matthew Walsh

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Management and outcomes for duodenal adenomas may vary based on etiology, familial versus sporadic. We reviewed the records of patients managed at our institution for duodenal adenomatous polyps for the 20-year period ending July 2006.

Discussion

Methods of polyp resection (endoscopic, local surgical resection, or definitive surgical resection) within both sporadic and familial patient groups were compared. Patients with known cancer were excluded. Two hundred seventy-eight patients with duodenal polyps were followed during this time period: 110 patients (39.6%) with sporadic polyps and 168 (60.4%) with familial adenomatous polyposis (FAP). Sporadic patients presented at a mean age of 66.5 years. Endoscopic resection was attempted in 44 patients (40%) with morbidity in 9% and local recurrence rate of 52% with a mean follow-up of 43 months. Surgical resection was performed in 46 patients (42%): 27 by definitive resection and local resection in 19. At a mean follow-up of 41 months, there were no local recurrences in the patients treated by definitive resection and six recurrences (32%) after local resection. Morbidity was 39%. There was a significant difference in local recurrence when comparing definitive resection to both endoscopic and local resection (p < 0.001, p = 0.002, respectively), but no significant difference between endoscopic and local excision (p = 0.13). Cancer was discovered in the surgical specimens of 11 patients (24%) with benign preoperative biopsies. FAP patients began surveillance at a mean age of 39.5 years, and mean surveillance duration was 100 months. Endoscopic resection/ablation was attempted in 40 patients (24%) with a morbidity of 7.5%. With a mean follow-up of 77.5 months, the local recurrence rate was 72.5%. Surgical resection was performed in 50 patients (30%) with a mean follow-up of 44 months. Definitive resection was performed in 47 and local excision in three with local recurrence rates of 9% and 100%, respectively. Surgical morbidity was 48%. Local recurrence was significantly lower following definitive resection compared to endoscopic or local resection (p < 0.001), but there was no difference in local recurrence between the latter two groups (p = 0.29). Four patients (8%) undergoing surgery were discovered to have invasive cancer despite benign endoscopic biopsies. In summary, endoscopic and local surgical management for both sporadic and familial duodenal polyps are associated with a high rate of local recurrence. Definitive resection in the form of pancreaticoduodenectomy, pancreas-sparing duodenectomy, or segmental duodenectomy offers the best chance for polyp eradication and prevention of carcinoma, regardless of polyp etiology.
Literatur
1.
Zurück zum Zitat Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Ann Surg Oncol 2007;14(11):3159–3167.CrossRefPubMed Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. Ann Surg Oncol 2007;14(11):3159–3167.CrossRefPubMed
2.
Zurück zum Zitat Bülow S, Björk J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F, Vasen HFA, the DAF Study Group. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53(3):381–386.CrossRefPubMed Bülow S, Björk J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F, Vasen HFA, the DAF Study Group. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004;53(3):381–386.CrossRefPubMed
3.
Zurück zum Zitat Galiatstatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101(2):385–398.CrossRef Galiatstatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101(2):385–398.CrossRef
4.
Zurück zum Zitat Farnell MB, Sakorafas GH, Sarr MG, Rowland CM, Tsiotos GG, Farley DR, Nagorney DM. Villous tumors of the duodenum: reappraisal of local vs. extended resection. J Gastrointest Surg 2000;4(1):13–21.CrossRefPubMed Farnell MB, Sakorafas GH, Sarr MG, Rowland CM, Tsiotos GG, Farley DR, Nagorney DM. Villous tumors of the duodenum: reappraisal of local vs. extended resection. J Gastrointest Surg 2000;4(1):13–21.CrossRefPubMed
5.
Zurück zum Zitat Penna C, Phillips RK, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis; experience of two European centres. Br J Surg 1993;80(8):1027–1029.CrossRefPubMed Penna C, Phillips RK, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis; experience of two European centres. Br J Surg 1993;80(8):1027–1029.CrossRefPubMed
6.
Zurück zum Zitat Mackey R, Walsh RM, Chung R, Brown N, Smith A, Church J, Burke C. Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 2005;9(8):1088–1093.CrossRefPubMed Mackey R, Walsh RM, Chung R, Brown N, Smith A, Church J, Burke C. Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 2005;9(8):1088–1093.CrossRefPubMed
7.
Zurück zum Zitat Gallagher MC, Shankar A, Groves CJ, Russell RC, Phillips RK. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 2004;91(9):1157–1164.CrossRefPubMed Gallagher MC, Shankar A, Groves CJ, Russell RC, Phillips RK. Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 2004;91(9):1157–1164.CrossRefPubMed
8.
Zurück zum Zitat Saurin J, Gutknecht C, Napolean B et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 2004;22:493.CrossRefPubMed Saurin J, Gutknecht C, Napolean B et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 2004;22:493.CrossRefPubMed
9.
Zurück zum Zitat Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999;49(3 pt 1):358–364.CrossRefPubMed Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999;49(3 pt 1):358–364.CrossRefPubMed
10.
Zurück zum Zitat Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142(5):761–768.CrossRefPubMed Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142(5):761–768.CrossRefPubMed
11.
Zurück zum Zitat Meneghetti AT, Safadi B, Stewart L, Way LW. Local resection of ampullary tumors. J Gastrointest Surg 2005;9(9):1300–1306.CrossRefPubMed Meneghetti AT, Safadi B, Stewart L, Way LW. Local resection of ampullary tumors. J Gastrointest Surg 2005;9(9):1300–1306.CrossRefPubMed
12.
Zurück zum Zitat Jordan PH, Ayala G, Rosenberg WR, Kinner BM. Treatment of ampullary villous adenomas that may harbor carcinoma. J Gastrointest Surg 2002;6(5):770–775.CrossRefPubMed Jordan PH, Ayala G, Rosenberg WR, Kinner BM. Treatment of ampullary villous adenomas that may harbor carcinoma. J Gastrointest Surg 2002;6(5):770–775.CrossRefPubMed
13.
Zurück zum Zitat Morpurgo E, Vitale GC, Galandiuk S, Kimberling J, Ziegler C, Polk HC. Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 2004;8(5):559–564.CrossRefPubMed Morpurgo E, Vitale GC, Galandiuk S, Kimberling J, Ziegler C, Polk HC. Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 2004;8(5):559–564.CrossRefPubMed
14.
Zurück zum Zitat Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783–785.CrossRefPubMed Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2:783–785.CrossRefPubMed
15.
Zurück zum Zitat Groves CJ, Saunders BP, Spigelman AD, Phillips RKS. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10-year prospective study. Gut 2002;50:636–641.CrossRefPubMed Groves CJ, Saunders BP, Spigelman AD, Phillips RKS. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10-year prospective study. Gut 2002;50:636–641.CrossRefPubMed
Metadaten
Titel
Outcome Based on Management for Duodenal Adenomas: Sporadic Versus Familial Disease
verfasst von
Michael David Johnson
Richard Mackey
Nancy Brown
James Church
Carol Burke
R. Matthew Walsh
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2010
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-009-1091-4

Weitere Artikel der Ausgabe 2/2010

Journal of Gastrointestinal Surgery 2/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.